The human data have two parts with different strength. The prospective learning/validation sub-cohorts predict incident MI/stroke/death over 3 years, which does mitigate reverse causation (the events postdate the measurement). But the large-n confirmation (1,876) is a cross-sectional association with prevalent CVD burden, where reverse causation and shared-cause confounding (diet, renal function, gut-microbiome differences that co-vary with disease) are not excluded, and adjustment for traditional risk factors cannot remove unmeasured confounders such as kidney function (a strong determinant of plasma TMAO and of CVD). Crucially the entire human cohort is drawn from patients referred for elective coronary angiography — a sick, high-baseline-risk, non-general population — so both the effect size and its generality to healthy people are uncertain. What upgrades these associations toward a causal reading is not their internal design but their coherence with the mouse necessity/sufficiency chain: a metabolite shown to cause atherosclerosis in mice and associated with events in humans is more plausibly causal in humans than a bare human correlation would be. Hence the human observations support, but do not on their own establish, that plasma TMAO is a causal cardiovascular risk factor in people.
Validity (step 6)
status: approved, reason_if_not_false: checked.
Traced. The step is a deliberately modest one: (i) the large-n confirmation (O-38, n=1,876) is cross-sectional, so reverse causation and shared-cause confounding — kidney function being the salient unmeasured one, a strong determinant of both plasma TMAO and CVD — are not excluded; (ii) even the prospective sub-cohort (O-37), which does postdate measurement to events and so mitigates reverse causation, is drawn entirely from patients referred for elective coronary angiography, a selected sick high-risk population, so both effect size and generality to healthy people are uncertain. From these, “observational data in a selected cohort cannot by itself establish causality” follows straightforwardly. The second clause — that the associations gain causal weight “mainly by riding on the strong mouse mechanism” — is a valid consilience/coherence point: a metabolite already shown causal in a mouse intervention model plus associated with human events is more plausibly causal in humans than a bare correlation. Because the conclusion is explicitly “supports but does not establish,” there is no over-reach for a defeater to attack; the step is self-limiting and holds. Approved.